Alliancebernstein L.P. Tenaya Therapeutics, Inc. Transaction History
Alliancebernstein L.P.
- $278 Billion
- Q2 2024
A detailed history of Alliancebernstein L.P. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 49,570 shares of TNYA stock, worth $95,670. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,570
Previous 33,180
49.4%
Holding current value
$95,670
Previous $173,000
11.56%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TNYA
# of Institutions
97Shares Held
55.6MCall Options Held
30.3KPut Options Held
600-
Column Group LLC San Francisco, CA9.4MShares$18.1 Million40.92% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.62MShares$14.7 Million0.36% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$13 Million1.81% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$7.86 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$6.78 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $79.8M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...